PLUS THERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Plus Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • Plus Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was 195 %.
  • Plus Therapeutics, Inc. annual Return On Equity for 2024 was 195 %.
  • Plus Therapeutics, Inc. annual Return On Equity for 2023 was -806 %, a 319% decline from 2022.
  • Plus Therapeutics, Inc. annual Return On Equity for 2022 was -192 %, a 68.8% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 195 +1K Jan 1, 2024 Dec 31, 2024
2023 -806 -613 -319% Jan 1, 2023 Dec 31, 2023
2022 -192 -78.4 -68.8% Jan 1, 2022 Dec 31, 2022
2021 -114 +251 +68.8% Jan 1, 2021 Dec 31, 2021
2020 -365 -4.33K -109% Jan 1, 2020 Dec 31, 2020
2019 3.96K +4.17K Jan 1, 2019 Dec 31, 2019
2018 -205 +24.8 +10.8% Jan 1, 2018 Dec 31, 2018
2017 -230 -57.7 -33.5% Jan 1, 2017 Dec 31, 2017
2016 -173 -2.18K -109% Jan 1, 2016 Dec 31, 2016
2015 2.01K -757 -27.4% Jan 1, 2015 Dec 31, 2015
2014 2.77K +5.7K Jan 1, 2014 Dec 31, 2014
2013 -2.93K +204 +6.52% Jan 1, 2013 Dec 31, 2013
2012 -3.13K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.